Advertisement

Topics

Search Results for "Warfarin In Vte"

13:54 EST 8th February 2016 | BioPortfolio

Matching Channels

Vitamin K

Vitamin K is a group of 2-methilo-naphthoquinone derivatives. There are three notable forms of vitamin K; K1 which can be synthesized by plants, K2 which can be formed by natural bacteria in the int...

Matching News

Caneston Bifonazole interaction with warfarin

The summary of product characteristics for Canesten Bifonazole Once Daily 1% w/w Cream (Bayer) now warns of a potential interaction with warfarin. Limited data suggests that an interaction between top...

Carbamazepine affects warfarin anticoagulation

(HealthDay)—For warfarin-treated patients, carbamazepine co-treatment is associated with subtherapeutic anticoagulative effect and increased warfarin dose requirements, according to a study publishe...

Warfarin, Sulfonylurea Combo Ups Severe Hypoglycemia Risk

The findings suggest a unique drug-drug interaction between warfarin and glipizide/glimepiride, with the greatest hypoglycemia risk at start of warfarin treatment. Medscape Medical News

Switch to Warfarin OK in Cancer-Linked Thrombosis (CME/CE)

(MedPage Today) -- Study indicates warfarin is not harmful

NOACs Cut Bleeding vs Warfarin Following Acute VTE

Dr Goldhaber reviews a meta-analysis he coauthored of RE-COVER trial data suggesting that new oral anticoagulants may be a better option than warfarin for treating acute VTE. theheart.org on Medscap...

Switch From LMWH to Warfarin OK in Cancer-Related Thrombosis

Switching from a low-molecular-weight heparin to warfarin is not associated with an increase in recurrent venous thromboembolism, major bleeding, or total bleeding. Medscape Medical News

Watchman Device Cheaper Over Lifetime than Warfarin, NOACs (CME/CE)

(MedPage Today) -- Watchman more cost-effective long-term than warfarin, NOACs

Warfarin Another Option for Cancer-Associated Thrombosis

Warfarin is an acceptable alternative to low-molecular-weight heparin for patients with cancer-associated thrombosis, according to a new study.

Matching PubMed Articles

Low-dose maternal warfarin intake resulting in fetal warfarin syndrome: In search for a safe anticoagulant regimen during pregnancy.

Fetal exposure to maternal ingestion of warfarin is known to produce certain dysmorphic features in the neonate, known as fetal warfarin syndrome (FWS). There is a general consensus that maternal inta...

Warfarin-induced skin necrosis following heparin-induced thrombocytopenia.

Anticoagulants, such as heparin and warfarin, are commonly used in the treatment and prevention of thromboembolic events. The risk of developing warfarin-induced skin necrosis (WISN) with warfarin is ...

Extreme warfarin hypersensitivity after oophorectomy.

We report the case of a woman who developed unexplained warfarin hypersensitivity after undergoing surgery to remove her ovaries. Presurgery, the patient's international normalised ratios (INR) contro...

Complex Disease, Partial Revascularization, and Adverse Outcomes in Patients Treated With Long-Term Warfarin Therapy Who Underwent Percutaneous Coronary Intervention.

Patients treated with warfarin who undergo percutaneous coronary intervention (PCI) present a difficult therapeutic problem. Their baseline demographics, procedural characteristics, and 12-month outco...

Warfarin resistance associated with genetic polymorphism of VKORC1: linking clinical response to molecular mechanism using computational modeling.

The variable response to warfarin treatment often has a genetic basis. A protein homology model of human vitamin K epoxide reductase, subunit 1 (VKORC1), was generated to elucidate the mechanism of wa...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement